Literature DB >> 30345429

Using Technology to Improve Adherence to HIV Medications in Transitional Age Youth: Research Reviewed, Methods Tried, Lessons Learned.

E S Spratt1, C E Papa1, M Mueller2, S Patel3, T Killeen4, E Maher5, C Drayton1, T C Dixon1, S L Fowler1, F Treiber2.   

Abstract

In transitional age youth living with HIV or AIDS, non-adherence (<80%) to anti-retroviral medication is associated with viral resistance, disease progression, and an increased risk of death. This feasibility study investigated the Maya MedMinder electronic pillbox and cell phone texting with personalized motivational interviewing strategies to improve medication adherence in non-adherent youth. Twenty patients out of 30 identified as non-adherent by the Pediatric HIV team at the Medical University of South Carolina were approached, and 15 were recruited (Ages 12 to 20; 13.3% male, 86.7% female; 100% African-American). Following baseline MedMinder monitoring, subjects were randomized to intervention groups with reminder signals on or off. The time medications were taken was collected by the MedMinder, resulting in adherence scores. All were interviewed for readiness to change utilizing the Motivational Interviewing (MI) Stages of Change scores. Viral load and CD4 labs were scheduled every 6 weeks. Despite monetary incentives and personalized support, recruitment and adherence to the protocol was a challenge. Only 6/15 subjects completed the entire study scheduled for 6-months .Stages of change scores revealed that those that transitioned to making changes had higher CD4 percentages midway through the study. Challenges included missed appointments and labs despite efforts by text and phone to schedule convenient appointment times with participants. Device challenges included the large size of the MedMinder and faulty electronic signaling, especially from rural areas. The methodology was feasible with these patients. This small feasibility study highlights that technological tools to promote adherence and motivational enhancement strategies in teens and young adults who are non-adherent to HIV medication regimens can enhance biomarker outcomes associated with medication adherence.

Entities:  

Keywords:  Adherence; Adolescents; HIV; Human immunodeficiency virus; Non-adherence

Year:  2017        PMID: 30345429      PMCID: PMC6195351     

Source DB:  PubMed          Journal:  J Gen Med (Dover)


  32 in total

1.  Healthy choices: motivational enhancement therapy for health risk behaviors in HIV-positive youth.

Authors:  Sylvie Naar-King; Kathryn Wright; Jeffrey T Parsons; Maureen Frey; Thomas Templin; Phebe Lam; Debra Murphy
Journal:  AIDS Educ Prev       Date:  2006-02

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  Motivational Enhancement System for Adherence (MESA): pilot randomized trial of a brief computer-delivered prevention intervention for youth initiating antiretroviral treatment.

Authors:  Sylvie Naar-King; Angulique Y Outlaw; Moussa Sarr; Jeffrey T Parsons; Marvin Belzer; Karen Macdonell; Mary Tanney; Steven J Ondersma
Journal:  J Pediatr Psychol       Date:  2013-01-28

4.  Barriers to HAART adherence among human immunodeficiency virus-infected adolescents.

Authors:  Debra A Murphy; Moussa Sarr; Stephen J Durako; Anna-Barbara Moscicki; Craig M Wilson; Larry R Muenz
Journal:  Arch Pediatr Adolesc Med       Date:  2003-03

5.  The use of cell phone reminder calls for assisting HIV-infected adolescents and young adults to adhere to highly active antiretroviral therapy: a pilot study.

Authors:  Joseph A Puccio; Marvin Belzer; Johanna Olson; Miguel Martinez; Cathy Salata; Diane Tucker; Diane Tanaka
Journal:  AIDS Patient Care STDS       Date:  2006-06       Impact factor: 5.078

6.  Adaptation of an HIV Medication Adherence Intervention for Adolescents and Young Adults.

Authors:  Idia B Thurston; Laura M Bogart; Madeline Wachman; Elizabeth F Closson; Margie R Skeer; Matthew J Mimiaga
Journal:  Cogn Behav Pract       Date:  2014-05

7.  Effect of a smartphone application incorporating personalized health-related imagery on adherence to antiretroviral therapy: a randomized clinical trial.

Authors:  Anna I Perera; Mark G Thomas; John O Moore; Kate Faasse; Keith J Petrie
Journal:  AIDS Patient Care STDS       Date:  2014-10-07       Impact factor: 5.078

8.  Outcomes of a multifaceted medication adherence intervention for HIV-positive patients.

Authors:  Kevin D Dieckhaus; Victoria Odesina
Journal:  AIDS Patient Care STDS       Date:  2007-02       Impact factor: 5.078

9.  A multisite randomized trial of a motivational intervention targeting multiple risks in youth living with HIV: initial effects on motivation, self-efficacy, and depression.

Authors:  Sylvie Naar-King; Jeffrey T Parsons; Debra Murphy; Karen Kolmodin; D Robert Harris
Journal:  J Adolesc Health       Date:  2010-02-04       Impact factor: 5.012

10.  Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial.

Authors:  Kim L Lavoie; Gregory Moullec; Catherine Lemiere; Lucie Blais; Manon Labrecque; Marie-France Beauchesne; Veronique Pepin; André Cartier; Simon L Bacon
Journal:  Patient Prefer Adherence       Date:  2014-11-10       Impact factor: 2.711

View more
  7 in total

1.  Promoting medication adherence from the perspective of adolescent and young adult kidney transplant recipients, parents, and health care professionals: A TAKE-IT TOO study.

Authors:  Christina Nguyen; Mary Amanda Dew; Taya Irizarry; Mary McNulty; Janet Rennick; Bärbel Knäuper; Annie Descoteaux; Audrey Grenier; Lovemine Jeannot; Bethany J Foster; Annette J DeVito Dabbs
Journal:  Pediatr Transplant       Date:  2020-05-10

2.  HIV pre-exposure prophylaxis adherence test using reverse transcription isothermal amplification inhibition assay.

Authors:  Jane Y Zhang; Yu Zhang; Andrew T Bender; Benjamin P Sullivan; Ayokunle O Olanrewaju; Lorraine Lillis; David Boyle; Paul K Drain; Jonathan D Posner
Journal:  Anal Methods       Date:  2022-03-31       Impact factor: 3.532

3.  Acceptability of short text messages to support treatment adherence among adolescents living with HIV in a rural and urban clinic in KwaZulu-Natal.

Authors:  Mthokozisi A Cele; Moherndran Archary
Journal:  South Afr J HIV Med       Date:  2019-10-03       Impact factor: 2.744

Review 4.  Behavioral Theories and Motivational Features Underlying eHealth Interventions for Adolescent Antiretroviral Adherence: Systematic Review.

Authors:  Alemitu Mequanint Bezabih; Kathrin Gerling; Workeabeba Abebe; Vero Vanden Abeele
Journal:  JMIR Mhealth Uhealth       Date:  2021-12-10       Impact factor: 4.773

Review 5.  Technologies for Medication Adherence Monitoring and Technology Assessment Criteria: Narrative Review.

Authors:  Madilyn Mason; Youmin Cho; Jessica Rayo; Yang Gong; Marcelline Harris; Yun Jiang
Journal:  JMIR Mhealth Uhealth       Date:  2022-03-10       Impact factor: 4.947

Review 6.  Applying Behavioural Insights to HIV Prevention and Management: a Scoping Review.

Authors:  Alexsandra Andrawis; James Tapa; Ivo Vlaev; Daniel Read; Kelly Ann Schmidtke; Eric P F Chow; David Lee; Christopher K Fairley; Jason J Ong
Journal:  Curr HIV/AIDS Rep       Date:  2022-08-05       Impact factor: 5.495

Review 7.  Psychosocial interventions for improving engagement in care and health and behavioural outcomes for adolescents and young people living with HIV: a systematic review and meta-analysis.

Authors:  Christina A Laurenzi; Stefani du Toit; Wole Ameyan; G J Melendez-Torres; Tashmira Kara; Amanda Brand; Yeukai Chideya; Nina Abrahams; Melissa Bradshaw; Daniel T Page; Nathan Ford; Nadia A Sam-Agudu; Daniella Mark; Marco Vitoria; Martina Penazzato; Nicola Willis; Alice Armstrong; Sarah Skeen
Journal:  J Int AIDS Soc       Date:  2021-08       Impact factor: 6.707

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.